Michael Jelinek to Protein Kinase Inhibitors
This is a "connection" page, showing publications Michael Jelinek has written about Protein Kinase Inhibitors.
Connection Strength
1.503
-
Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains? J Clin Oncol. 2019 11 01; 37(31):2807-2814.
Score: 0.661
-
Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy. Clin Lung Cancer. 2019 11; 20(6):e597-e600.
Score: 0.660
-
Adjuvant Osimertinib: A New Standard of Care. Oncologist. 2021 04; 26(4):263-265.
Score: 0.181